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ABSTRACT
The aim of this study was to develop and validate 2 
protocols (for use on-farm and at a central location) for 
the reduction of Mycobacterium avium ssp. paratubercu-
losis (MAP) in colostrum while preserving beneficial im-
munoglobulins (IgG). The on-farm protocol was based 
on curdling of the colostrum, where the IgG remain 
in the whey and the MAP bacteria are trapped in the 
curd. First, the colostrum was diluted with water (2 vol-
umes colostrum to 1 volume water) and 2% rennet was 
added. After incubation (1 h at 32°C), the curd was cut 
and incubated again, after which whey and curd were 
separated using a cheesecloth. The curd was removed 
and milk powder was added to the whey. Approxi-
mately 1 log reduction in MAP counts was achieved. A 
reduction in total proteins and IgG was observed due to 
initial dilution of the colostrum. After curd formation, 
more than 95% of the immunoglobulins remained in the 
whey fraction. The semi-industrial protocol was based 
on centrifugation, which causes MAP to precipitate, 
while the IgG remain in the supernatant. This protocol 
was first developed in the laboratory. The colostrum 
was diluted with skimmed colostrum (2 volumes colos-
trum to 1 volume skimmed colostrum), then skimmed 
and centrifuged (at 15,600 × g for 30 min at room 
temperature). We observed on average 1.5 log reduction 
in the MAP counts and a limited reduction in proteins 
and IgG in the supernatant. To obtain a semi-industrial 
protocol, dairy pilot appliances were evaluated and the 
following changes were applied to the protocol: after 
2:1 dilution as above, the colostrum was skimmed and 
subsequently clarified, after which the cream was heat 
treated and added to the supernatant. To investigate 
the effect of the colostrum treatment on the nutritional 
value and palatability of the colostrum and the IgG 
transfer, an animal experiment was conducted with 24 
calves. Six received the dam’s colostrum, 6 were given 
untreated purchased colostrum (control), and 2 groups 
of 6 calves received colostrum treated according to 
both of the above-mentioned methods. No significant 
differences were found between the test groups and the 
dam’s colostrum group in terms of animal health, IgG 
uptake in the blood serum, milk, or forage uptake. Two 
protocols to reduce MAP in colostrum (for use on-farm 
or at a central location) were developed. Both methods 
preserve the vital IgG.
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INTRODUCTION
Mycobacterium avium ssp. paratuberculosis (MAP) 
is the causal agent of Johne’s disease, a contagious, 
chronic, and often lethal enteritis. Johne’s disease 
results in reduced milk yields and negative economic 
consequences. Calves younger than 1 yr are the most 
susceptible to MAP infection. Possible transmission 
routes for calves are contaminated colostrum and milk; 
contaminated feed or water; environmental contamina-
tion (barn environment, manure, dust, and aerosols) 
and to a lesser extent in utero or through contaminated 
sperm (Sweeney, 1996; Diéguez et al., 2008; Eisenberg 
et al., 2010, 2015; Mortier et al., 2013).
The present study focused on the elimination of colos-
tral transmission because colostrum is the first milk the 
calf receives after parturition and can be considered as a 
first possible MAP source. Colostrum is vital to the calf 
as it contains maternal immunoglobulins (IgG), which 
neonatal calves lack as they are agammaglobulinemic 
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at birth. Calves gain their immunity through ingestion 
and absorption of colostral IgG, which is characterized 
by the presence of at least 10 mg of IgG per mL of 
blood serum 24 to 48 h after birth. Colostrum also 
contains essential nutrients such as vitamins, growth 
factors, and maternal cells (Gauthier et al., 2006; God-
den, 2008; Houser et al., 2008). At present, only one 
research group enumerated the MAP bacteria present 
in the colostrum of subclinical and clinical cows: results 
obtained by PCR demonstrated up to 24 ± 12 cfu/
mL and 254 ± 63 cfu/mL in colostrum of subclinical 
and clinical cows, respectively (Stabel et al., 2014). At 
present, the infectious dose of MAP is unknown. It is 
expected that low numbers of MAP are sufficient to 
infect a calf (Begg and Whittington, 2008; Eisenberg 
et al., 2010). Reducing the number of MAP in colos-
trum could reduce the intake of MAP and subsequently 
reduce the risk of infection. Farmers would benefit by 
either decontaminating the colostrum on-farm or treat-
ing their cows’ colostrum at a nearby central location.
Several methods have the potential to decontaminate 
colostrum such as pasteurization. Pasteurization has 
important drawbacks: Godden et al. (2015) found no 
long-term benefits when feeding heat-treated colostrum 
to calves and pasteurization equipment is prohibitively 
expensive for on-farm use. Curdling is effective and 
more appropriate for on-farm use as it is easy, inexpen-
sive, and does not require any special equipment. Van 
Brandt et al. (2010) demonstrated that after curdling 
the majority (80–90%) of MAP cells can be found in 
the curd, whereas the IgG remain in the whey. Cen-
trifugation is another valuable option, one often used 
to concentrate MAP for improved detection. Gao et al. 
(2005) increased the detection sensitivity of MAP by 
centrifuging bulk tank milk and analyzing the pellet 
and cream fraction. Because centrifugation is already 
frequently applied under (semi-)industrial circumstanc-
es for separating or clarifying milk and cream, centrifu-
gation has potential for use within a semi-industrial 
protocol (SIP) for MAP decontamination.
In the current project, we developed 2 protocols for 
MAP decontamination: an on-farm protocol (FP) based 
on curdling and a SIP based on centrifugation with po-
tential application in a central location. First, we aimed 
to develop and validate both methods to reduce MAP 
in colostrum under laboratory conditions with special 
attention to the conservation of IgG and other essential 
nutrients. Second, we adapted the protocols for on-farm 
use and at the central location, validated them with 
naturally contaminated colostrum, and performed an 
animal experiment to assess the influence of the treated 
colostra on the calves’ health (several parameters) and 
IgG uptake in their blood.
MATERIALS AND METHODS
Bacterial Strains and Culture Preparation
In the first part of the project (experiments to opti-
mize MAP removal from colostrum), a Mycobacterium 
smegmatis strain (MB4355; ILVO collection) was used 
as a replacement for MAP, because this bacterium 
forms colonies on tryptone soy agar (TSA; CM0131; 
Oxoid, Basingstoke, UK) after 3 d of incubation at 
37°C. This choice facilitated the laboratory experi-
ments (Hussain et al., 2016). One week before an ex-
periment, the M. smegmatis strain was inoculated on 
TSA. After 3 d of incubation at 37°C, one loopful of 
this culture was added to tryptone soy broth (TSB; 
CM0129, Oxoid) with glass beads (to prevent clumping 
of the culture). This suspension was incubated for 3 
d on a shaker at 37°C. Subsequently, the culture was 
drawn into a syringe and expelled 20 times through a 
0.8 × 40 mm needle (BD Microlance; BD Biosciences, 
Louth, Ireland) to break up any large clumps. Finally, 
the optical density at 540 nm of this suspension was 
measured and adjusted with TSB to a value of 1.15, 
which corresponds to approximately 109 cfu/mL. A 
decimal dilution of the suspension was made to dilution 
10−8. Next, the colostrum sample was inoculated with 
the appropriate dilution. The inoculated colostrum was 
incubated for 1 h at 40°C to allow the bacteria to bind 
to the colostrum particles and subsequently incubated 
overnight at 4°C on a shaker.
The protocol was validated using a MAP strain 
(MB3840). This strain was grown on Herrold’s egg yolk 
medium for 3 mo at 37°C. For 1 L of Herrold’s egg 
yolk medium, 9 g of bacteriological peptone (LP0037; 
Oxoid), 4.5 g of NaCl (CL00.1249.5000; ChemLab, 
Zedelgem, Belgium), 15.3 g of technical agar (LP0011; 
Oxoid), 2.7 g of beef extract (B4888; Sigma-Aldrich, 
Steinheim, Germany), 4.1 g of sodium pyruvate (P2256; 
Sigma-Aldrich), and 27 mL of glycerol (8.18709.1000; 
Merck, Darmstadt, Germany) were added to 970 mL 
of distilled water. The pH was adjusted to 7.8 with 10 
M NaOH (1.06462.1000; Merck) and the medium was 
boiled to dissolve the agar. After sterilization (121°C for 
15 min) and cooling to 56°C, the following supplements 
were added: one vial of 2 mg of Mycobactin J (Synbiot-
ics, Lyon, France) resuspended in 4 mL of 95% ethanol 
(CL00.0505.500, ChemLab); 6 egg yolks and 5 mL of a 
filter-sterilized (0.22-μm Millipore filter) 2% Malachite 
green solution (1.01398.0025; Merck). The day before 
the experiment, Ringer’s solution was applied onto the 
plate and the culture was scraped off using a loop after 
which the bacterial culture was drawn into a syringe 
and treated as described above for M. smegmatis.
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For the M. smegmatis experiments, the number of M. 
smegmatis was determined for the culture, the inocu-
lated colostrum (after overnight incubation), and the 
obtained whey and supernatant samples (see below). 
For the culture, 100 μL of the 10−5 to 10−8 dilutions 
were plated out in triplicate onto TSA. For the in-
oculated colostrum, whey and supernatant 10-fold dilu-
tions were made in Ringer’s solution and 100 μL of each 
dilution was plated out in triplicate on TSA. After 3 d 
of incubation at 37°C, colonies were counted.
For the MAP experiments, the MAP presence was 
determined as described above on Middlebrook agar 
(7H10; Becton Dickinson, Le Pont de Claix, France), 
supplemented with one vial of 2 mg of Mycobactin J 
and 1 bottle of oleic albumin dextrose catalase supple-
ment (212240; Becton Dickinson and Company, Lover-
ton, UK) with an incubation period of 3 mo at 37°C.
Colostrum Samples
Colostrum was obtained from Melkcontrole Centrum 
Vlaanderen (Lier, Belgium). This colostrum originated 
from various farms. It was delivered in 10-L contain-
ers, thawed, and poured into 1-L bottles. All colostrum 
was sterilized by gamma rays (dose: 15 kGy; Synergy 
Health, Etten-Leur, the Netherlands). Before each ex-
periment, the sterility of the colostrum was confirmed 
by bacteriological analysis.
For some centrifugation experiments, skimmed colos-
trum was needed. Colostrum was diluted in a 2:1 ratio 
of 2 volumes colostrum to 1 volume water (abbrevi-
ated below as “diluted 2:1 with water” or “diluted 2:1 
with skimmed colostrum” as appropriate) to approach 
the viscosity of milk. The diluted colostrum was then 
heated to 43°C to dissolve all fat globules and skimmed 
using a separator (Van Houte, Gent, Belgium). The 
skimmed colostrum was divided into 1-L bottles and 
gamma sterilized as described above.
For validation of the methods, naturally MAP-
contaminated colostrum (n = 16) was obtained from 
lactating seropositive cows (n = 7), a heifer born from 
a seropositive cow (n = 1), or lactating cows in a para-
tuberculosis (paraTBC) positive herd (n = 8). Di-
ergezondheidszorg Vlaanderen (Lier, Belgium) kindly 
provided this colostrum from farmers registered in the 
Belgian paraTBC program.
Viscosity Measurement of Colostrum, Milk,  
and Diluted Colostrum
Skim milk, whole milk, colostrum (n = 1) and 12 
dilutions of this colostrum sample [9 volumes colostrum 
(C):1 volume water (W), 5C:1W, 4C:1W, 3C:1W, 
2C:1W, 1C:1W, 1C:2W, 1C:2W, 1C:3W, 1C:4W, 
1C:5W, and 1C:9W, respectively] were measured with a 
Brookfield digital viscometer (DV-II + Pro Brookfield 
Engineering Labs Inc., Stoughton, MA) using the small 
sample adapter (Brookfield Engineering Labs Inc.).
Curdling Experiments for Optimizing  
the On-Farm Protocol
A flowchart with an overview of the curdling experi-
ments is given in Figure 1.
Experiment 1: Best Rennet Type and Optimi-
zation of the Rennet Concentration for Curdling 
of Colostrum. Three rennet types were purchased at 
Brouwmarkt (Almere, the Netherlands): rennet powder 
[2,200 international milk-clotting units (IMCU)/g], 
vegetarian rennet (190 IMCU/g), and calf rennet (100 
IMCU/g). In the first experiment, various concentra-
tions of each rennet type were added to 40 mL of colos-
trum (n = 1): 0.03% (vol/vol), 0.06, 0.1, 0.5, 1, and 2%. 
The curdling treatment was to incubate the colostrum 
for 1 h at 32°C, cut the curd, incubate for another hour 
at 32°C, and separate whey and curd using a cheese-
cloth. After curdling, the presence/absence of whey and 
(if present), whey volume was noted.
Experiment 2: Effect of Curdling Undiluted 
and 2:1 Diluted Colostrum on the Presence of M. 
smegmatis. The effect of 2 concentrations (1 and 2%) 
of the 3 rennet types were compared for undiluted (n = 
3) and colostrum diluted 2:1 with sterile water (n = 3) 
to which approximately 108 or 105 cfu M. smegmatis/
mL were added as described above. Both undiluted and 
diluted colostrum were divided over 18 sterile 50-mL 
tubes (containing 1 or 2% of the 3 rennet types, 3 tubes 
per condition). Curdling was performed as described 
in experiment 1. The presence of M. smegmatis in the 
inoculated colostrum and all whey samples was deter-
mined as described above.
Experiment 3: Effect of Diluting Colostrum 
with Milk or Water on M. smegmatis Presence. 
Colostrum (n = 3) was diluted in a 2:1 ratio with sterile 
water or purchased UHT milk to determine whether 
this had an effect on the curdling and the M. smegmatis 
presence in whey. Approximately 108 or 105 cfu of M. 
smegmatis/mL were added as described above. Each co-
lostrum sample was subdivided into three 50-mL tubes 
containing 2% calf rennet and curdling was performed 
as described above. Mycobacterium smegmatis counts 
were determined on the inoculated colostra and whey 
fractions as described above.
Experiment 4: Validation of the Curdle Proto-
col with MAP. Nine colostrum samples were used. For 
validation, we used a concentration close to naturally 
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contaminated colostrum (102–103 cfu/mL; Stabel et al., 
2014). In addition, 107 cfu/mL was added as a control 
concentration. Colostrum with the lowest MAP dose 
was divided into three 50-mL tubes and each colostrum 
sample with the highest MAP dose into 2 tubes; each 
tube contained 2% calf rennet. Curdling was performed 
Figure 1. Flowcharts of the experiments performed to obtain the on-farm protocol (FP) and semi-industrial protocol (SIP), validation, and 
animal experiment. MAP =  Mycobacterium avium ssp. paratuberculosis. M. Smegmatis = Mycobacterium smegmatis. All centrifugations were 
performed at room temperature.
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as described above. The MAP counts were determined 
on Middlebrook agar for all inoculated colostra and 
whey samples as previously described.
Centrifugation Experiments for Optimizing  
the Semi-Industrial Protocol
We also optimized a SIP with the aim of using it at a 
central location. First, we determined the specifications 
for centrifuges used in the dairy processing: milk sepa-
rators have a relative centrifugal force around 15,600 
× g and semi-industrial centrifuges operate at approxi-
mately 43,400 × g. An overview of the centrifugation 
experiments is given in Figure 1.
Experiment 5: Effect of Centrifuging 2:1 
Diluted and Undiluted Colostrum on the M. 
smegmatis Precipitation. We added approximately 
108 or 105 cfu M. smegmatis/mL to colostrum (n = 3) 
and colostrum diluted 2:1 with sterile water (n = 3). 
Three subsamples of each colostrum type (V = 40 mL 
per subsample) were centrifuged for 30 min at 15,600 
× g and 43,400 × g at room temperature (RT) using 
a Sorvall centrifuge (Rotor: T29; Sorvall Lynx 6000, 
Thermo Scientific, Waltham, MA). The M. smegmatis 
counts were determined for the inoculated colostra and 
all supernatants on TSA as previously described.
Experiment 6: Effect of Diluting Colostrum 
with Water, Milk, or Skimmed Colostrum on 
the Precipitation of M. smegmatis After Cen-
trifugation. Colostrum (n = 3) was diluted 2:1 with 
water, purchased UHT milk, or skimmed colostrum 
(see above). Approximately 108 cfu of M. smegmatis/
mL were added to the colostrum. Three subsamples (V 
= 40 mL) of the 6 diluted colostra were centrifuged for 
30 min at 15,600 × g at RT. The M. smegmatis counts 
on the supernatants were done as described above.
Experiment 7: Effect of Manually Skimming 
Colostrum on Precipitation of M. smegmatis. 
Two colostrum samples were spiked with M. smegmatis 
(108 or 105 cfu M. smegmatis/mL) after which the colos-
trum was divided into 2 parts. One part was skimmed 
(i.e., the colostrum was centrifuged for 30 min at 12,000 
× g at RT), after which the samples were put on ice. 
After 15 min, we removed the cream using a spatula and 
the supernatant was put in a centrifugation tube. Then 
2 subsamples of each skimmed and whole colostrum (V 
= 40 mL) were centrifuged for 30 min at 15,600 × g at 
RT to remove M. smegmatis. Presence of M. smegmatis 
in the supernatants was determined as described above.
Experiment 8: Effect of Skimming Colostrum 
Using a Separator on Presence of M. smegmatis. 
This experiment was a scaled-up version of experiment 
7. Due to the large volumes needed for this process (V 
= 10 L), we only skimmed 3 colostrum samples. All 
colostra were diluted in a 2:1 ratio with skimmed colos-
trum and 105 cfu of M. smegmatis/mL was added to 2 
samples and 108 cfu/mL to 1 sample. These colostrum 
samples were heated to 43°C to dissolve all fat globules 
and then skimmed in the separator. Three subsamples 
of the skimmed colostrum was centrifuged for 30 min 
at 15,600 × g at RT. The M. smegmatis counts were 
performed on the obtained cream, skimmed colostrum, 
and supernatants as described above.
Experiment 9: Validation of the Centrifuga-
tion Protocol with MAP. During this experiment, 
the final method was validated with MAP to mimic 
naturally contaminated colostrum. For this experiment, 
we used 9 colostrum samples. All samples were diluted 
2:1 with skimmed colostrum. Half of each sample was 
inoculated with 108 cfu of MAP/mL; the other half was 
inoculated with 102 to 103 cfu of MAP/mL. One 50-mL 
tube of colostrum with the highest MAP dose and two 
50-mL tubes of colostrum with the lowest MAP dose 
were centrifuged for 30 min at 15,600 × g at RT, after 
which we manually removed the cream and determined 
the MAP counts in the supernatants on Middlebrook 
agar.
Validation of the Protocols with Naturally 
Contaminated Colostrum Samples
We divided the received colostrum samples into 2 
parts (Figure 1). One part, diluted 2:1 with sterile wa-
ter, was subjected to the on-farm method. The other 
part, diluted 2:1 with skimmed colostrum, was subject-
ed to the SIP. After applying the SIP, we pasteurized 
the cream at 70°C for 30 min in a hot water bath and 
determined the MAP presence after inoculating 100 
μL in triplicate on Middlebrook agar. We determined 
the MAP concentration of all untreated colostrum, di-
luted colostrum, whey, and reconstituted supernatant 
samples (mixing supernatant with pasteurized cream) 
as follows: a dilution series was made up to 10−2 and 
100 μL of each dilution was plated in triplicate on 
Middlebrook agar. We also chemically decontaminated 
these samples with N-acetyl-l-cysteine as described 
by Bradner et al. (2013) and Stabel et al. (2014) to 
improve MAP detection, after which a decimal dilution 
up to dilution 10−2 was plated (100 μL) in triplicate on 
Middlebrook agar.
On all culture-positive samples (diluted colostrum, 
whey, or supernatant), we also performed a DNA iso-
lation procedure using the Adiapure Paratb milk kit 
(BioMerieux/Adiagene, Saint-Brieuc, France). Sub-
sequently, we performed an in-house developed and 
validated real-time PCR based on the IS900 sequence 
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for the quantification of MAP. We added 5 μL of the 
obtained DNA to 20 μL of PCR mixture consisting of 
12.50 μL of TaqMan Environmental Mastermix (Ap-
plied Biosystems, Warrington, UK), 0.75 μL of forward 
(F) primer (600 nM, DH2 F: 3′-GCCTTCGACTACAA-
CAAGAGC-5′; Eurogentec), 0.75 μL of reverse (R) 
primer (600 nM, DH2 R: 3′-GCGTCGGGAGTTTG-
GTAG-5′; Eurogentec), 0.25 μL of probe (200 nM, 
3′-GCCGCGCTG ATCCTGCTTACT-5′; Eurogentec) 
and water. The PCR reaction was as follows: 1 cycle 
of 10 min at 95°C, 40 cycles of 15 s at 95°C, and 1 
min at 60°C followed by on cycle of 15 min at 40°C. A 
DNA standard curve of MAP strain MB 3835 (ILVO 
collection, 106 to 102 genomes/μL) was used to convert 
the obtained Ct-values into genome and subsequent cell 
concentrations.
Protein and IgG Content of the Samples
From each colostrum, diluted colostrum, whey, and 
supernatant sample, the total protein and IgG concen-
tration and changes in protein fractions were deter-
mined.
The Coomassie Plus (Bradford) Assay kit (23236; 
Thermo Scientific, Rockford, IL) was used to deter-
mine the total protein concentration of the samples 
and was performed according to the manufacturer’s 
protocol (https://tools.thermofisher.com/content/sfs/
manuals/MAN0011203_CoomassiePlus_Bradford_
Asy_UG.pdf).
To study the various protein fractions in the samples, 
a SDS-PAGE was performed as described by Laem-
mli (1970). Six standards (all from Sigma-Aldrich, 
St. Louis, MO) were included for identification of the 
protein fractions: α-casein (C6780), β-casein (C6905), 
β-LG (L-0130), lactoferrin (L4765), gamma-globulin 
(G5009), and protein standard (P5369). The low mo-
lecular weight calibration kit (17–0446–01; Amersham 
Pharmacia Biotech, Buckinghamshire, UK) was used as 
a marker for weight determination.
To determine the IgG concentration in the samples, 
an in-house-developed gel filtration method was used. 
In short, the samples were prepared according to the 
International Dairy Federation standard 178:1996 (IDF, 
1996) and were subsequently diluted 20 times with elu-
tion buffer (20 mM Tris and 150 mM NaCl). Gel filtra-
tion was performed using a Yarra 3u SEC-2000 column 
(00H-4512-K0; Phenomenex, Torrance, CA) connected 
with the HPLC PE series 200 equipped with a Detec-
tor UV/VIS series 200 set at 280 nm (Perkin Elmer, 
Waltham, MA). An IgG standard curve (concentration 
range between 2 and 10 mg/mL; G5009–25G; Sigma-
Aldrich) was measured and the response (ratio of peak 
area) was plotted against the concentration. This curve 
was used to determine the IgG concentration in the 
samples.
Animal Experiment
This animal experiment was approved by ILVO Eth-
ics Committee (application number: 2015/246) and the 
animals were treated in an ethical manner according to 
the guidelines for care and use of agricultural animals 
in research and teaching. After the experiment, the 
calves remained in the ILVO herd.
We purchased 220 L of colostrum at European Colos-
trum Industry (Marloie, Belgium). This commercially 
available colostrum is sterile, has specified characteris-
tics (70 g/L of Ig; 14% proteins; 6.0% fat and infectious 
bovine rhinotracheitis free) and was delivered in 1-L 
bottles. All colostrum was thawed and pooled. Sixty 
liters of the pooled sample was immediately poured 
into 1-L bottles and frozen at −20°C (control). The 
FP was performed on 90 L of colostrum: 45 L of tepid 
water was added and the resulting mixture was heated 
to 32°C in a cheese tank. Subsequently, we added 2% 
of calf rennet, and after 1 h of incubation at 32°C, 
we cut the curd and continued incubation for another 
hour. The whey and curd were then separated using 
a cheesecloth. The whey was poured into 1-L bottles 
and frozen. Before feeding the thawed whey to the 
calf, 120 g of milk powder (Excellent, Denkavit, the 
Netherlands) was added. The SIP was performed on 
70 L of colostrum. First, 20 L of colostrum was di-
luted 2:1 with water, heated to 43°C, and skimmed. 
The skimmed colostrum was added to the remaining 
50 L; this mixture was again heated to 43°C and then 
skimmed. The cream was pasteurized for 30 min at 
70°C above boiling water (au bain marie). The skimmed 
colostrum was clarified with the Easycream I (GEA 
Westfalia, Oelde, Germany). We added the inactivated 
cream to the clarified colostrum and homogenized the 
mixture, after which it was poured into 1-L bottles and 
frozen. One bottle of each type was used to determine 
the protein and IgG concentration as described above.
Four groups consisting of 6 Holstein-Friesian heifer 
calves were included in the experiment (Figure 1): one 
group receiving colostrum from its respective dam (own 
group), one group receiving nontreated colostrum from 
the pool (control group), one group receiving colostrum 
treated according to the FP, and one group receiving 
colostrum treated according to the SIP. The calves were 
born into the ILVO herd between April and December 
2015. At birth, the calves were successively allocated 
to 1 of the 4 groups in order: control, SIP, FP, and 
own group. Only female calves and calves originating 
from cows, not heifers (to ensure sufficient colostrum 
production), were included in the experiment.
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At birth, all calves were weighed. All calves were fed 
at the same time: each received 2 L of colostrum within 
2 h after birth, another 2 L around 6 h after birth, 
another 2 L around 12 h after birth, and the remain-
ing 4 L within the next day. When a calf belonged to 
one of the experimental groups, the respective colos-
trum was thawed in a warm water bath at 40°C. The 
IgG content of the colostrum was estimated using a 
digital refractometer (Obione calf, Obione, Charentay, 
France). When the calves did not voluntary consume 
the colostrum within 6 h after birth, probe feeding 
was applied. The consumed volume of each calf was 
noted and the intake of the colostrum was noted (very 
easy, normal, difficult, or probed). We lack intake data 
for last 3 calves, born into the own group. After the 
colostrum period, the calves were all fed twice daily 
with a commercial milk formula (Denkavit Excellent 
milk powder, 1 L/10 kg of weight). They also received 
an ILVO-made concentrate (F09–53, maximum 3 kg), 
water ad libitum, and hay ad libitum. Weaning hap-
pened around 8 wk of age, when the calf had consumed 
a total of 5.25 kg of concentrate the week before. The 
calves were housed in individual pens until the age of 4 
mo, after which they were grouped. In the groups, they 
received silage feed (maize/prewilted grass silage) and 
an ILVO-made concentrate (F14–33, maximum 1.5 kg 
per calf).
Blood samples were taken approximately 72 h after 
birth and sent to DGZ Vlaanderen to determine the 
amount of IgG in blood serum. The calves were weighed 
every 2 wk up to the age of 16 wk and then monthly 
until the end of the experiment (6 mo of age). The daily 
milk and concentrate intake was individually noted. 
The general health (presence of diarrhea or illness) and 
antibiotic intake of each calf were also monitored.
Statistical Analysis
The number of replicates was 3 in all experiments, 
except in the validation experiments (experiment 4 and 
9). This number of colostrum samples was calculated, 
using the power procedure (SAS, overall F-test for 
1-way ANOVA). The group means of the preliminary 
experiments (results from experiments 2 and 5), a 95% 
interval and a nominal power of 0.8 were used. For 
validation purposes (experiments 4 and 9), we used 9 
colostrum samples, to which a low and high MAP con-
centration had been added. The colostrum was divided 
into subsamples (3 with low concentration and 2 with 
high concentration). A 2-sided t-test was performed 
when comparing the bacterial counts as dependent 
variable in experiments 2, 5, 7, and 8 with the bacterial 
counts as variable and the 2 conditions (for example, 
adding 1 or 2% of rennet) as the grouping variables. For 
experiments 3 and 6, we performed an ANOVA to com-
pare the bacterial count results (dependent variable) 
of various treatments (independent variables) on the 
colostrum samples. During the animal experiment, a 
general linear model analysis was done using treatment 
group and time as fixed effects and cow as random ef-
fect to determine the effect on the dependent variables: 
IgG blood value, weight gain, and colostrum, milk, and 
forage intake. For all analyses, a P-value smaller than 
0.05 was considered significant.
RESULTS AND DISCUSSION
Mycobacterium avium ssp. paratuberculosis causes a 
lethal, chronic enteritis known as Johne’s disease that 
reduces milk yields and results in negative economic 
consequences. Intake of contaminated colostrum is one 
of the possible contamination routes for young calves. 
Decontamination of colostrum (with conservation of 
the IgG) before feeding the calves might reduce this 
contamination route. Our goal was to develop 2 decon-
tamination protocols, one with the potential to be used 
on the farm (FP; a cheap, easy-to-use, and practical 
method based on curdling) and one with the potential 
to be used at a central location (SIP; based on centrifu-
gation). To the best of our knowledge, this study is the 
first attempt to decontaminate colostrum by means of 
curdling and centrifugation.
On-Farm Protocol (Based on Curdling)
Experiment 1 involved adding various concentrations 
of 3 rennet types (rennet powder, vegetarian rennet, 
and calf rennet) to colostrum. When less than 0.1% of 
rennet was added, no curdling reaction was observed. 
Addition of 0.5% rennet resulted in a curdle reaction, 
but without clear separation of whey and curd. Upon 
addition of 1 or 2% of rennet, a clear separation of 
whey and curd occurred. These results were the similar 
for all 3 rennet types.
The density of colostrum (4 times denser than milk, 
see below) may explain the higher rennet percentage 
needed for curdling. We measured the viscosity of water, 
milk, colostrum, and different dilutions of colostrum 
(diluted with water). For milk, we observed a viscosity 
of 2.28 cP, which is 4 times lower than the viscosity of 
colostrum. When the colostrum was diluted either 2:1 
or 1:1 with water, this resulted in a viscosity similar to 
milk (data not shown). As our goal was to maintain as 
many IgG in the decontaminated colostrum as possible, 
we used the 2:1 dilution ratio in subsequent experi-
ments.
During the second experiment, we assessed the influ-
ence of (1) the rennet concentration (1 or 2%), (2) the 
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rennet type (rennet powder, vegetarian, or calf rennet), 
and (3) diluting the colostrum on the M. smegmatis 
counts (Figure 2). When comparing addition of 1 and 
2% rennet to the diluted inoculated colostrum, we 
found no statistically significant differences (P-values 
between 0.19 and 0.95, 2-sided t-test). For the undiluted 
colostrum, a statistical difference was observed for the 
rennet powder (for the sample with the high dose, P 
= 0.040, 2-sided t-test) and the calf rennet (P = 0.027 
and P = 0.002 for the low and high dose, respectively, 
2-sided t-test). Using 2% rennet guarantees an effective 
curdle reaction. For the 2% rennet concentration, we 
observed a statistical difference between the calf ren-
net and the other rennet types: calf rennet gave better 
results than the others (P = 0.021 calf vs. powder, P = 
0.009 calf vs. vegetarian, 2-sided t-test). We therefore 
decided to use calf rennet during subsequent experi-
ments. Compared with the results of Van Brandt et al. 
(2010), our rennet percentage was remarkably higher 
(0.03 vs. 2%, respectively). The only difference between 
both studies is that they curdled skimmed colostrum, 
whereas we curdled whole colostrum. After curdling, we 
observed for the undiluted colostrum with the low M. 
smegmatis dose on average a 1.22 ± 0.12 log reduction 
and for the high dose on average a 1.00 ± 0.28 log 
reduction. For the diluted colostrum, we observed on 
average a 0.79 ± 0.21 log and 0.97 ± 0.21 log reduction 
for the samples with the low and high dose of M. smeg-
matis, respectively (Figure 2). We found that diluting 
the colostrum did not have an additional effect on the 
M. smegmatis reduction (P-values between 0.05 and 
0.98, 2-sided t-test). However, throughout preliminary 
experiments, we observed that when using undiluted 
colostrum not all samples curdled (2 of 10 colostrum 
samples), whereas all samples of the 2:1 diluted colos-
trum curdled. Despite little additional reduction in M. 
smegmatis, we chose to include diluting the colostrum 
in the protocol to be sure that curdling happens for 
each colostrum.
We assessed the effect of curdling colostrum diluted 
2:1 with water versus milk on the M. smegmatis counts 
in experiment 3. Diluting with milk would supplement 
Figure 2. Results (mean ± SD, n = 3) of the Mycobacterium smegmatis counts of the (2:1 diluted) inoculated colostrum before curdling and 
of the whey samples after curdling with either 1 and 2% rennet powder, 1 and 2% of vegetarian rennet, or 1 and 2% of calf rennet. 
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the colostrum with additional proteins, which could be 
beneficial for calves. When using the highest M. smeg-
matis dose, we observed a 1.95 and 1.63 log reduction 
after curdling of colostrum diluted with milk and wa-
ter, respectively, whereas a 0.98 and 1.84 log reduction, 
respectively, was obtained when the low dose was used. 
No significant difference was observed when comparing 
the log reductions in colostrum inoculated with the high 
dose (P = 0.89, ANOVA), and a significant difference 
was observed for the low dose (P < 0.001, ANOVA). 
Because milk addition would represent an additional 
cost to the farmers and the milk would curdle as well, 
dilution with water was chosen.
Besides observing reduction in M. smegmatis, we also 
investigated the effect of curdling on the proteins and 
more specifically IgG present in the whey. In general, 
we observed a first decrease in total protein concen-
tration when adding water to the colostrum, which 
also affected the IgG concentration. After the diluted 
colostrum was curdled, a further decline in total pro-
tein concentration was observed, mainly due to the 
formation of the curd by the caseins. During the curdle 
step, the majority of the IgG remained in the whey (on 
average throughout the experiments, we found no more 
than a 5% loss; Figure 3).
From these results, we obtained a protocol that 
is cheap, easy to use, and practical for farmers. The 
protocol, validated during experiment 4, is as follows. 
First, dilute the colostrum 2:1 with water and add 2% 
of calf rennet. Incubate for 1 h at 32°C, cut the curd, 
and incubate again for 1 h at 32°C. Afterward, separate 
the whey and curd using a cheesecloth (or similar). 
The added concentrations in the validation experiment 
(experiment 4) mimicked the natural contamination of 
colostrum. On average, we found 0.85 log MAP reduc-
tion (between 0.46 and 1.59 log) in the samples with 
the low MAP dose and 1.03 log reduction (between 1.02 
and 1.27 log reduction) in the samples with the high 
MAP dose. We observed lower reductions compared 
with Van Brandt et al. (2010): they described 2.65 to 
3.32 log reduction after curdling. Several explanations 
are possible for the observed difference. Van Brandt et 
al. (2010) skimmed colostrum, which reduced the num-
ber of MAP by about 1 log before curdling. In addition, 
they separated the whey and curd after a centrifugation 
step, which differs from our separation step with the 
cheesecloth. It is likely that centrifugation resulted in 
a more clear whey, whereas small pieces of curd could 
pass through the cheese cloth. However, skimming and 
centrifugation were not included in the optimization of 
our FP as this protocol should be as practical and as 
inexpensive as possible for the farmer.
Stabel et al. (2014) determined the amount of MAP in 
colostrum of subclinical and clinical cows and found 1.3 
and 2.3 log cfu/mL, respectively. The present protocol 
seems to be sufficient to decontaminate colostrum from 
subclinical cows but not from clinical cows. Because the 
infectious dose is unknown, it is possible that the pres-
ent FP is sufficiently efficient to decrease the number 
of MAP in colostrum of clinical cows to amounts below 
the infectious dose.
Semi-Industrial Protocol (Based on Centrifugation)
To investigate whether diluting the vis-
cous colostrum has an effect on the presence of 
M. smegmatis, we centrifuged undiluted and 2:1 diluted 
colostrum with water at 2 centrifugal forces (experi-
ment 5). When centrifuging the undiluted colostrum 
inoculated with 108 cfu/mL for 30 min at 15,600 × g 
and 43,400 × g, we observed a 0.96 and 0.92 log re-
duction, respectively. In case of the diluted colostrum, 
we found 2.60 and 2.30 log reduction with the same 
conditions, respectively. When the lowest M. smegmatis 
concentration was added to both undiluted and diluted 
colostrum, the results were below the detection limit 
(<2 log/mL). The diluted colostrum contained 5 log M. 
smegmatis per mL before centrifuging and the superna-
tant contained less than 2 log, implying that at least 3 
log reduction was achieved. The observed differences in 
log reduction between undiluted and diluted colostrum 
were statistically significant (P < 0.001 for both forces, 
2-sided t-test). As no statistical significant difference 
was observed between the 2 gravitational forces on 
the M. smegmatis of the diluted colostrum (P = 0.71, 
2-sided t-test), 15,600 × g was used for the following 
experiments.
Milk or skimmed colostrum can also be used to dilute 
the colostrum. Diluting with milk or skimmed colos-
trum will add proteins, nutrients, and in case of the 
latter also IgG, as investigated in experiment 6. When 
centrifuging diluted colostrum, we found 2.40, 1.98, and 
2.77 log reduction after centrifuging colostrum diluted 
with water, milk, and skimmed colostrum, respectively 
(Figure 4). The log reduction, obtained after centri-
fuging colostrum diluted with skimmed colostrum was 
statistically different from the others (P = 0.0002 for 
skimmed vs. water and P = 0.0001 for skimmed vs. 
milk, ANOVA). We decided to use diluting colostrum 
with skimmed colostrum in the protocol, because of the 
addition of IgG (see below).
Skimming also reduces the viscosity of colostrum. 
After manual skimming, a reduction of approximately 
0.84 log was found when centrifuging the colostrum 
with a high M. smegmatis dose, a significant difference 
(P = 0.0001, 2-sided t-test; data not shown). These 
results are comparable to Van Brandt et al. (2010) 
who noted counts of 0.81 and 1.02 log MAP retrieved 
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from manually derived cream. For technical reasons, no 
results could be obtained for the colostra with the low 
concentration of M. smegmatis.
We also assessed mechanical skimming using a 
separator in experiment 8, where 0.34 to 0.72 log M. 
smegmatis was found in the cream fractions. A statisti-
cal difference was found when comparing M. smegmatis 
counts for the colostrum before and after skimming (P 
= 0.002, 2-sided t-test; Figure 5). When we centrifuged 
the skimmed colostrum, we found 0.95 and 1.62 log 
reduction with the colostrum inoculated with the low 
dose and high dose, respectively. During this process, a 
total reduction of 1.5 to 2 log could be observed.
The effects of centrifugation on the proteins and more 
specifically IgG present in the supernatant were also 
examined. As expected, diluting the colostrum with 
skimmed colostrum had less effect on the total protein 
and IgG concentration than diluting with water. After 
Figure 3. Example of the total protein and IgG determination of colostrum 3 during the validation experiment for the centrifugation and 
curdle protocol. For this colostrum, the results are shown for (A) the total protein determination using the Coomassie blue protein assay, (B) 
the IgG determination using gel filtration, and (C) the identification of the protein fractions, using SDS-PAGE (lane 1: reference proteins, lane 
2: β-LG, lane 3: gamma-globulin, lane 4: lactoferrin, lane 5: protein standard, lane 6: β-casein, lane 7: α-casein, lane 8: reference proteins, lane 
9: skimmed colostrum, lane 10: colostrum 3, lane 11: colostrum 2:1 diluted with water, lane 12: whey after curdling with 2% rennet, lane 13: 
colostrum 2:1 diluted with skimmed colostrum, lane 14: supernatant obtained after centrifuging for 30 min at 15,600 × g, and lane 15: reference 
proteins with the molecular weights). All centrifugations were performed at room temperature.
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Figure 4. Results (mean ± SD, n = 3) of the Mycobacterium smegmatis counts before and after centrifugation of colostrum 2:1 with water 
or milk and inoculated with the highest M. smegmatis concentration.
Figure 5. Results (mean ± SD, n = 6) of the Mycobacterium smegmatis counts before and after skimming and after centrifuging of the co-
lostrum diluted 2:1 with skimmed colostrum and inoculated with a low or high dose of M. smegmatis.
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centrifugation, the majority of the IgG remained in the 
supernatant (in general we found no more than 5% loss 
throughout the experiments; Figure 3).
Based on the results, the following SIP was proposed 
and validated with MAP (experiment 9). First, colos-
trum is diluted 2:1 with skimmed colostrum. Next, the 
colostrum is centrifuged for 30 min at 15,600 × g to 
separate cream and supernatant separated. On average, 
a 1.29 ± 0.27 log reduction (between 0.94 and 1.65 log) 
in MAP was detected when centrifuging the 2:1 diluted 
colostrum with the low dose of MAP. For the colostrum 
with the high dose of MAP, on average 1.27 ± 0.15 log 
reduction was observed.
For the decontamination of colostrum originating 
from cows with a subclinical infection (1.3 log cfu/
mL), this protocol suffices. For the decontamination 
of colostrum originating from cows with symptoms 
(2.3 log cfu/mL), this protocol will not suffice (Stabel 
et al., 2014). Note that this protocol was optimized 
under laboratory conditions. In those experiments, for 
practical reasons skimming occurred manually during 
the validation. In a separator, however, the circulat-
ing system physically separates supernatant and cream 
throughout the skimming process.
Validation with Naturally Contaminated Samples
We obtained 16 colostrum samples: 7 originating 
from a seropositive cow (colostrum 1, 2, 3, 5, 7, 9, and 
16), 1 from a heifer born from a seropositive cow (co-
lostrum 15), and 8 from cows in a paraTBC-positive 
herd (colostrum 4, 6, 8, 10, 11, 12, 13, 14, and 15). Six 
colostrum samples (colostrum 2, 7, 12, 14, 15, and 16) 
were considered negative (the results of all MAP counts 
were <10 cfu/mL). We performed MAP counts on the 
samples with and without a chemical decontamination 
procedure as described by Bradner et al. (2013): MAP 
was found in 7 colostrum samples (colostrum 1, 3, 5, 
9, 10, 11, and 13) for both treatments, in 2 samples 
only after decontamination, and in 1 sample without 
decontamination (Table 1). On average, we observed 
2.2 ± 0.16 cfu of MAP/mL in the positive colostrum 
samples, close to the counts from colostrum of clinical 
cows as reported by Stabel et al. (2014). Although the 
farmers in this study were all subjected to the Belgian 
paraTBC program, the presence of “clinical” cows was 
not mentioned. It is possible that these “subclinical” 
cows intermittently shed more MAP as previously 
reported (Mortier et al., 2014). Another possibility is 
that our methodology is more sensitive compared with 
the one used by Stabel et al. (2014) due to the medium 
used.
No MAP was observed in the whey and supernatants 
of these samples, indicating that both protocols resulted 
in a MAP reduction of at least 1.2 to 2.2 log reduction, 
which appears sufficient for the decontamination of 
these samples. After pasteurization of the cream, we 
retrieved no MAP. When we performed the quantita-
tive (q)PCR on the original samples, we unexpectedly 
detected no MAP-DNA. The samples contained ap-
proximately 2 log of MAP, which is more or less the 
detection limit of the qPCR. It is possible that the 
number was too low to detect in the qPCR.
Adaptation of the Protocols for On-Farm Use  
and Use at a Central Location
After performing the final FP, we obtained whey 
with immunoglobulins, but without caseins, an im-
Table 1. Overview of Mycobacterium avium ssp. paratuberculosis 
(MAP) counts, determined with and without initial chemical 
decontamination procedure of the colostrum as described by Bradner 
et al. (2013)1
Sample
MAP count  
(average log cfu/mL ± SD)
No  
decontamination  
procedure
Decontamination  
procedure
Colostrum 1 2.28 ± 0.08 2.59 ± 0.07
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 3 2.07 ± 0.16 1.98 ± 0.19
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 4 <1 2.10 ± 0.14
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 5 2.65 ± 0.20 2.62 ± 0.31
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 6 2.33 ± 0.03 <1
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 8 <1 1.85 ± 0.19
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 9 2.38 ± 0.09 2.16 ± 0.12
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 10 2.21 ± 0.12 2.05 ± 0.25
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 11 2.36 ± 0.08 2.27 ± 0.08
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
Colostrum 13 2.03 ± 0.51 2.01 ± 0.15
 Whey (FP) <1 <1
 Supernatant (SIP) <1 <1
1The counts are shown for each colostrum sample (as received from the 
farmer), for each whey sample obtained after performing the on-farm 
method (FP), and for each supernatant obtained after performing the 
semi-industrial protocol (SIP). The MAP counts of colostrum samples 
2, 7, 12, 14, 15, and 16 were all negative. Negative results are indicated 
in the table as <1 log cfu/mL.
Journal of Dairy Science Vol. 100 No. 5, 2017
MYCOBACTERIUM REDUCTION IN COLOSTRUM 3509
portant protein source for the calves. To supplement 
this whey, we added the milk powder which the calves 
would receive at an older age to the whey after thawing 
and before administration to the calf. This step aims 
to add extra nutrients to the whey to partially correct 
for the lost proteins. Visually this colostrum was less 
dense than the regular colostrum and it is difficult to 
estimate the effect of the treatment on the composition 
and palatability of this reconstituted whey.
We also adapted the validated SIP based on cen-
trifugation with equipment used in the dairy industry. 
In a first step, colostrum is diluted 2:1 with skimmed 
colostrum, heated to 43°C (to dissolve the fat globules), 
and skimmed with a separator. The obtained cream is 
pasteurized at 70°C for 30 min over boiling water (au 
bain marie). We choose this heating protocol because 
pasteurization for 1 h at 60°C or 15 s at 72°C has been 
reported as insufficient to consistently reduce MAP in 
milk and colostrum (Grant et al., 2005; Hammer et 
al., 2014). We also performed a preliminary experiment 
to determine the temperature effective in eliminating 
MAP (data not shown). The obtained skimmed colos-
trum was subsequently clarified using the Easycream 
I. After clarification, cream and clarified colostrum 
were mixed and homogenized. We expect to achieve a 
higher log reduction than observed in the experiments 
as 2 subsequent centrifugation steps are used, which 
will be sufficient for the decontamination of colostrum 
originating from clinical cows. In addition, these appli-
ances have a closed centrifugation system, where the 
supernatant is centrifuged more thoroughly than in the 
laboratory.
Animal Experiment
For the animal experiment, colostrum was prepared 
according to the developed protocols described above. 
The calves need at least 200 g of IgG to obtain a IgG 
blood value of at least 10 g of IgG/L of blood serum 
(lower limit of passive transfer; Godden, 2008; Godden 
et al., 2012). The pool (control colostrum) contained 61 
g of IgG/L, whereas the colostrum prepared with the 
curdle and centrifugation protocol contained 49 and 54 
g of IgG/L, respectively. These values were considered 
high enough as the calves received 6 L of colostrum 
within 24 h after birth.
We evaluated different parameters during this ani-
mal experiment. Approximately 72 h after birth, we 
determined the IgG amount in the blood serum (Figure 
6). Lower values were observed in the 3 test groups 
compared with the group that received colostrum from 
their dam. However, this difference was not statisti-
cally significant, given the large variation in the own 
group. This is probably due to intercow variations 
in the colostrum quality or intercalf variations in the 
blood values as described previously (Alley et al., 2012; 
Morrill et al., 2012; Yang et al., 2015). For the test 
groups, we worked with standardized purchased colos-
trum, which should have a fixed IgG content of 70 g of 
IgG/L. In spite of this, the blood values in these groups 
were lower, which indicates that these groups received 
fewer IgG than expected. One possibility is that the 
IgG amount decreased during the preparation process. 
It has been reported that the IgG amount decreases 
if the colostrum has undergone 3 freeze-thaw cycles, 
which was the case during the preparation (Morrill et 
al., 2015). Measurement of the IgG amount revealed 
only 61 g of IgG/L instead of the standardized 70 g/L. 
Another possibility is that the treatment of the colos-
trum changes the structure of the colostrum, resulting 
in a lower IgG uptake. During the animal trial, we esti-
mated the IgG content of each bottle of colostrum with 
a refractometer. Because of the changes in structure 
(e.g., dilution, addition of milk powder), the results of 
the treated colostrum samples are not useful.
Besides the blood values, we also assessed the ease of 
intake of the colostrum (5 intakes per calf). All calves 
consumed 10 L of colostrum within 24 h after birth, 
except for one calf from the HP group that consumed 
9 L and 2 calves from the own group that consumed 
9.5 L of colostrum each. The majority of the own group 
drank very easily or normally (Figure 7) and no calves 
needed probe feeding. We observed that the majority 
of intakes (67 and 83%) of the control and SIP group, 
respectively, happened either easily or normally. One 
calf of the control group (1 intake) and one calf of the 
SIP group (2 intakes) required probe feeding. The re-
sults of the FP group differed from the other groups: 
only 34% of the feedings were categorized as very easy 
or normal, whereas 40% were difficult. Three out of 
6 calves required one probe feeding and 2 calves re-
quired 4 probe feedings each (27% of all feedings of 
this group). Normally the calves of the ILVO herd only 
require very sporadic probe feedings as was observed in 
the own group (internal communication).
The calves had a birth weight of 38.8 ± 0.97 kg and 
an average weight of 117.9 ± 8.72 kg after 16 wk. We 
observed no statistically significant difference in weight 
gain between the groups, except at 16 wk, where a sig-
nificant difference was observed between the own group 
(1.18 kg/wk) and the others (control: 0.91 kg/wk, FP: 
0.78 kg/wk, and SIP: 0.86 kg/wk; P = 0.008). No sig-
nificant differences were observed between the milk and 
forage intakes of the calves in the test groups.
One calf of the SIP group died from colitis and one 
calf from the control group died from intestinal perfo-
ration. In total, 19 antibiotic treatments were given: 
one in the own group, 5 in the control group, 6 in the 
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SIP group (3 treatments were given to the calf that 
later died), and 7 in the FP group (2 calves received 
3 treatments each). When comparing the number of 
treatment days relative to the total duration of the ex-
periment, the calves of the control, SIP, and FP groups 
received on average 3.83, 4.33, and 5.17 d of treatment, 
respectively, as opposed to 0.50 d in the own group. 
Unfortunately, during the time period when the first 9 
Figure 6. IgG blood serum results (mean ± SD, n = 3) of the calves belonging to the 4 test groups (own, control, SIP, and FP) in the animal 
experiment. The average of each group is indicated. SIP = semi-industrial protocol; FP = farm protocol.
Figure 7. Total colostrum intake of all calves in the animal experiment. The results are shown as a percentage. SIP = semi-industrial pro-
tocol; FP = farm protocol.
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calves were born and allocated to the 3 test groups, a 
Salmonella infection was diagnosed on the farm where 
the experiment was conducted. This resulted in diar-
rhea and antibiotic treatment of some calves. After the 
birth of the first 9 calves, this infection was absent for 
the remaining period of the experiment. Therefore, we 
cannot exclude that the higher occurrence of illness and 
antibiotics treatment in the test groups is related to a 
higher infection risk during the first weeks/months of 
the animal experiment. For the remaining duration of 
the experiment, the observed diarrhea scores were the 
same for all groups (data not shown).
We compared different parameters and found that 
even though the on-farm colostrum was less attractive 
to the calves and more calves of this group needed to 
be probe fed, in general the animals from this group 
performed well. On some Belgian farms, calves are rou-
tinely probed to be certain of the ingested volume of 
colostrum; in such cases this protocol could be applied. 
On farms, where probing is uncommon, the on-farm 
treatment protocol could negatively affect colostrum 
intake. This study was based on the use of purchased 
sterile colostrum; treatment of fresh and naturally con-
taminated colostrum and its effect on colostrum intake 
must also be studied.
CONCLUSIONS
We have optimized 2 decontamination protocols for 
MAP under laboratory conditions. The FP, based on 
curdling, has the potential to be used on the farm and 
results in at least 1 log reduction in MAP counts with 
a limited loss of IgG. The SIP was developed to be 
used at a central location and resulted in at least 1.5 
log reduction in MAP counts and a limited loss of IgG. 
Both protocols were adapted for use based on place of 
treatment: for on-farm use, we added milk powder to 
the whey fraction before giving it to the calf. For ap-
plication in a central location, we used equipment from 
the dairy industry (resulting in 2 centrifugation steps, 
which will increase the MAP reduction). Both methods 
were validated using artificially and naturally contami-
nated colostra. We also administered these uninfected 
treated colostra to calves, and found no significant dif-
ferences between the test groups. For future work, it 
would be interesting to assess whether these treatments 
have an effect on other pathogens as well.
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